Salvage Therapy Post Pomalidomide-Based Regimen in Relapsed/Refractory Myeloma

被引：0

作者：

Fouquet, Guillemette ^{[1
]}

Karlin, Lionel ^{[2
]}

Macro, Margaret ^{[3
]}

Caillot, Denis ^{[4
]}

Roussel, Murielle ^{[5
]}

Arnulf, Bertrand ^{[6
]}

Pegourie, Brigitte ^{[7
]}

Petillon, Marie-Odile ^{[8
]}

Marit, Gerald ^{[9
]}

Mathiot, Claire ^{[10
]}

Kolb, Brigitte ^{[11
]}

Stoppa, Anne-Marie ^{[12
]}

Brechignac, Sabine ^{[13
]}

Rodon, Philippe ^{[14
]}

Dib, Mamoun ^{[15
]}

Tiab, Mourad ^{[16
]}

Legros, Laurence ^{[17
]}

Banos, Anne ^{[18
]}

Wetterwald, Marc ^{[19
]}

Garderet, Laurent ^{[6
]}

Royer, Bruno ^{[20
]}

Hulin, Cyrille ^{[21
]}

Benboubker, Lotfi ^{[22
]}

Decaux, Olivier ^{[23
]}

Escoffre, Martine ^{[24
]}

Fermand, Jean-Paul ^{[25
]}

Moreau, Philippe ^{[26
]}

Avet-Loiseau, Herve

Attal, Michel ^{[27
]}

Facon, Thierry ^{[1
]}

Leleu, Xavier ^{[28
]}

机构：

[1] CHRU Lille, Hop Claude Huriez, Malad Sang, F-59037 Lille, France

[2] Ctr Hosp Lyon Sud, Serv Hematol, F-69310 Pierre Benite, France

[3] Hop Cote Nacre, Caen 9, France

[4] Hop Bocage, Dijon, France

[5] Hop Purpan, Toulouse, France

[6] Hop St Louis, Paris, France

[7] Hop Albert Michallon, CHU Grenoble, Grenoble, France

[8] CHU Lille, Serv Malad Sang, F-59037 Lille, France

[9] CHU, Bordeaux, France

[10] IFM, Paris, France

[11] Hop Robert Debre, Reims, France

[12] Inst J Paoli I Calmettes, F-13009 Marseille, France

[13] Univ Paris 13, Hop Avicenne, AP HP, Hematol Clin, Bobigny, France

[14] Ctr Hosp, Hematol, Perigueux, France

[15] Hop Bocage, CHU, Hematol, Angers, France

[16] Hop la Roche Sur Yon, La Roche Sur Yon 9, France

[17] CHU Nice, Hop Archet 1, Dept Hematol, F-06202 Nice, France

[18] CH Cote Basque, Dept Hematol, Bayonne, France

[19] CHD Dunkerque, Dunkerque, France

[20] Ctr Hosp Univ, Hematol, Amiens, France

[21] Hop Brabois, Serv Hematol, CHRU, Nancy, France

[22] CHU Tours, Tours, France

[23] CHU Rennes, Dept Internal Med, Rennes, France

[24] CHU Rennes, Rennes, France

[25] Hop St Louis, AP HP, Serv Immunohematol, Paris, France

[26] Univ Nantes, Nantes, France

[27] Inst Univ Canc Toulouse Oncopole, Toulouse, France

[28] Hop Mil, Serv H, Poitier, France

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma
Fouquet, Guillemette
Karlin, Lionel
Macro, Margaret
Caillot, Denis
Roussel, Murielle
Arnulf, Bertrand
Pegourie, Brigitte
Petillon, Marie Odile
Mathiot, Claire
Hulin, Cyrille
Kolb, Brigitte
Stoppa, Anne-Marie
Brechiniac, Sabine
Rodon, Philippe
Dib, Mamoun
Tiab, Mourad
Richez, Valentine
Araujo, Carla
Wetterwald, Marc
Garderet, Laurent
Royer, Bruno
Perrot, Aurore
Benboubker, Lotfi
Decaux, Olivier
Escoffre-Barbe, Martine
Fermand, Jean Paul
Moreau, Philippe
Avet-Loiseau, Herve
Attal, Michel
Facon, Thierry
Leleu, Xavier
[J]. ANNALS OF HEMATOLOGY, 2018, 97 (05) : 831 - 837
[2] Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma
Guillemette Fouquet
Lionel Karlin
Margaret Macro
Denis Caillot
Murielle Roussel
Bertrand Arnulf
Brigitte Pegourie
Marie Odile Petillon
Claire Mathiot
Cyrille Hulin
Brigitte Kolb
Anne-Marie Stoppa
Sabine Brechiniac
Philippe Rodon
Mamoun Dib
Mourad Tiab
Valentine Richez
Carla Araujo
Marc Wetterwald
Laurent Garderet
Bruno Royer
Aurore Perrot
Lotfi Benboubker
Olivier Decaux
Martine Escoffre-Barbe
Jean Paul Fermand
Philippe Moreau
Hervé Avet-Loiseau
Michel Attal
Thierry Facon
Xavier Leleu
[J]. Annals of Hematology, 2018, 97 : 831 - 837
[3] Response to a novel pomalidomide-based therapy in a patient with relapsed multiple myeloma
Strifler, S.
Unzicker, C.
Einsele, H.
Knop, S.
[J]. ONKOLOGIE, 2011, 34 : 165 - 165
[4] Retrospective study on pomalidomide-PACE as a salvage regimen in aggressive relapsed and refractory multiple myeloma
Gezer, Deniz
Nogueira, Melanie Schmitt
Kirschner, Martin
Bruemmendorf, Tim H.
Mueller-Tidow, Carsten
Goldschmidt, Hartmut
Raab, Marc S.
Giesen, Nicola
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2024,
[5] Pomalidomide-based therapy for extramedullary multiple myeloma
Li, Yating
Ji, Jiamei
Lu, Hua
Li, Jianyong
Qu, Xiaoyan
[J]. HEMATOLOGY, 2022, 27 (01) : 88 - 94
[6] Pomalidomide-based therapy in Relapsed/Refractory Multiple Myeloma: a real-world single-center experience.
Fucci, Ludovica
Fiori, Luciano
Coppetelli, Ugo
Cimino, Giuseppe
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S144 - S145
[7] Management of Adverse Events Associated with Pomalidomide-Based Combinations in Patients with Relapsed/Refractory Multiple Myeloma
Nadeem, Omar
Ailawadhi, Sikander
Khouri, Jack
Williams, Louis
Catamero, Donna
Maples, Kathryn
Berdeja, Jesus
[J]. CANCERS, 2024, 16 (05)
[8] A Meta-analysis on the Efficacy of Pomalidomide-based Therapies for the Treatment of relapsed/refractory multiple Myeloma after Prior Lenalidomide Therapy
Weisel, K.
Davies, F. E.
Leleu, X.
Vogel, P.
Dhanasiri, S.
Le Nouveau, P.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 143 - 144
[9] Pomalidomide, Cyclophosphamide and Dexamethasone (PCD) is an Effective Salvage Regimen for Multiple Myeloma (MM) Patients Relapsed and/or Refractory to Daratumumab
Brioli, Annamaria
Mancuso, Katia
Ernst, Thomas
Hilgendorf, Inken
Zamagni, Elena
Heidel, Florian
Stauch, Thomas
Hochhaus, Andreas
von Lilienfeld-Toal, Marie
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 129 - 130
[10] Use of pomalidomide-based regimens in relapsed/refractory multiple myeloma (RRMM) in four European countries - findings from PREAMBLE
Goldschmidt, H.
Moreau, P.
Chen, C.
Davis, C.
Cook, G.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 280 - 281

← 1 2 3 4 5 →